Physician profile
Spiro Khoury
NPI 1740591155
$1,864.75
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2020: $165 · 2021: $64.29 · 2022: $97.73 · 2023: $361 · 2024: $43.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342 · Travel and Lodging: $38.32 · Education: $24.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.88 |
| Travel and Lodging | $38.32 |
| Education | $24.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $426.19 | 2019-2020 | |
| Boston Scientific Corporation | $347.50 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $310.40 | 2019 | |
| Medtronic USA, INC. | $193.89 | 2019-2020 | |
| Nevro Corp. | $90.36 | 2019 | |
| Medtronic, INC. | $64.29 | 2021 | |
| Curonix LLC | $62.85 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Merck Sharp & Dohme LLC | $43.79 | 2024 | Bridion |
| Scilex Pharmaceuticals INC. | $32.75 | 2019 | |
| Horizon Therapeutics Plc | $30.30 | 2019 | |
| Forte Bio-Pharma LLC | $28.70 | 2023 | Prolate, Nalocet |
| Novartis Pharmaceuticals Corporation | $27.17 | 2019 | |
| Arbor Pharmaceuticals, INC. | $25.96 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.75 | 2019 | |
| Pacira Therapeutics, INC. | $24.88 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.20 | 2019 | |
| Grifols USA, LLC | $16.50 | 2023 | Gamunex-C |
| Spinal Simplicity, LLC | $15.52 | 2023 | Ha Minuteman G3-R |
| Lilly USA, LLC | $14.63 | 2019 | |
| Pfizer INC. | $14.19 | 2019 | |
| Mdd US Operations, LLC | $13.58 | 2019 | |
| Collegium Pharmaceutical, INC. | $12.88 | 2019 | |
| Biodelivery Sciences International, INC. | $12.87 | 2019 | |
| Stimwave Technologies Incorporated | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spiro Khoury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.